Skip to main content

Peer Review reports

From: The unique transcriptional response produced by concurrent estrogen and progesterone treatment in breast cancer cells results in upregulation of growth factor pathways and switching from a Luminal A to a Basal-like subtype

Original Submission
28 Mar 2015 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
16 Oct 2015 Editorially accepted
24 Oct 2015 Article published 10.1186/s12885-015-1819-3

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us